Juan Sanchez | VP, Corporate Communications & IR |
Sharon Mates | Co-Founder, Chairman, CEO & President |
Mark Neumann | EVP & Chief Commercial Officer |
Lawrence Hineline | SVP, Finance, CFO, Treasurer & Assistant Secretary |
Suresh Durgam | EVP & Chief Medical Officer |
Andrew Tsai | Jefferies |
Brian Abrahams | RBC Capital Markets |
Michael DiFiore | Evercore ISI |
Ami Fadia | Needham & Company |
Ashwani Verma | UBS |
David Amsellem | Piper Sandler & Co. |
Marc Goodman | SVB Securities |
Graig Suvannavejh | Mizuho Securities |
Charles Duncan | Cantor Fitzgerald |
Good morning, ladies and gentlemen, and welcome to intracellular Therapies Third Quarter Earnings Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions].
As a reminder, today's conference call is being recorded.